JP2022511366A5 - - Google Patents
Info
- Publication number
- JP2022511366A5 JP2022511366A5 JP2021517453A JP2021517453A JP2022511366A5 JP 2022511366 A5 JP2022511366 A5 JP 2022511366A5 JP 2021517453 A JP2021517453 A JP 2021517453A JP 2021517453 A JP2021517453 A JP 2021517453A JP 2022511366 A5 JP2022511366 A5 JP 2022511366A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- compound
- branched
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306280.1 | 2018-09-28 | ||
| EP18306280.1A EP3628660A1 (en) | 2018-09-28 | 2018-09-28 | Donecopride and flucopride as neuroprotective agents in the treatment of neurodegenerative diseases |
| PCT/EP2019/076229 WO2020065028A1 (en) | 2018-09-28 | 2019-09-27 | Donecopride as neuroprotective agent in the treatment of neurodegenerative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511366A JP2022511366A (ja) | 2022-01-31 |
| JPWO2020065028A5 JPWO2020065028A5 (https=) | 2022-10-05 |
| JP2022511366A5 true JP2022511366A5 (https=) | 2022-10-05 |
Family
ID=63798921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517453A Pending JP2022511366A (ja) | 2018-09-28 | 2019-09-27 | 神経変性疾患の処置における神経保護剤としてのドネコプリド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220031680A1 (https=) |
| EP (2) | EP3628660A1 (https=) |
| JP (1) | JP2022511366A (https=) |
| KR (1) | KR20210098429A (https=) |
| CN (1) | CN113195452A (https=) |
| AU (1) | AU2019346024B2 (https=) |
| BR (1) | BR112021005952A2 (https=) |
| CA (1) | CA3115342A1 (https=) |
| SG (1) | SG11202103070VA (https=) |
| WO (1) | WO2020065028A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3166060A1 (fr) | 2024-09-12 | 2026-03-13 | Université De Caen Normandie | Composition pharmaceutique formulée pour être administrée par voie intranasale et utilisable pour le traitement d’une maladie neurodégénérative |
| FR3166146A1 (fr) | 2024-09-12 | 2026-03-13 | Université De Caen Normandie | Sel de fumarate de 1-(4-amino-5-chloro-2-méthoxyphényl)-3-[1-(cycloheptylméthyl)-4-pipéridinyl]propan-1-one –Composition pharmaceutique et utilisation associées |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| FR2904113A1 (fr) | 2006-07-21 | 2008-01-25 | Exonhit Therapeutics S A Sa | Procedes et outils pour la therapie de pathologies neurodegeneratives |
| CN102355902A (zh) * | 2009-01-24 | 2012-02-15 | 植物药物公共有限公司 | 神经营养因子介导的病症的处理 |
| FR3006686A1 (fr) * | 2013-06-05 | 2014-12-12 | Univ Caen | Composes inhibiteurs de l'acetylcholinesterase et agonistes des recepteurs serotoninergiques 5ht4, a effet promnesiant, leurs procedes de preparation et compositions pharmaceutiques les contenant |
| KR101824154B1 (ko) * | 2013-12-16 | 2018-03-14 | 수벤 라이프 사이언시스 리미티드 | 5-ｈｔ４ 수용체 작용제로서 인다졸 화합물 |
-
2018
- 2018-09-28 EP EP18306280.1A patent/EP3628660A1/en not_active Withdrawn
-
2019
- 2019-09-27 US US17/280,217 patent/US20220031680A1/en not_active Abandoned
- 2019-09-27 BR BR112021005952-0A patent/BR112021005952A2/pt unknown
- 2019-09-27 KR KR1020217009149A patent/KR20210098429A/ko not_active Ceased
- 2019-09-27 EP EP19783459.1A patent/EP3856716A1/en active Pending
- 2019-09-27 SG SG11202103070VA patent/SG11202103070VA/en unknown
- 2019-09-27 CN CN201980063618.3A patent/CN113195452A/zh active Pending
- 2019-09-27 CA CA3115342A patent/CA3115342A1/en active Pending
- 2019-09-27 JP JP2021517453A patent/JP2022511366A/ja active Pending
- 2019-09-27 AU AU2019346024A patent/AU2019346024B2/en not_active Ceased
- 2019-09-27 WO PCT/EP2019/076229 patent/WO2020065028A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008511635A5 (https=) | ||
| JP2022511366A5 (https=) | ||
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| JP2022023952A5 (https=) | ||
| JP2010523623A5 (https=) | ||
| JP2008540393A5 (https=) | ||
| JP2015108116A5 (https=) | ||
| JP2019537624A5 (https=) | ||
| BRPI0519113A2 (pt) | composiÇço de cura, fluoropolÍmero, composiÇço de fluoroelastâmero, artigo conformado, e, mÉtodos para produzir uma composiÇço de fluoropolÍmero, um artigo de fluoropolÍmero, e o agente de cura | |
| JP2010534246A5 (https=) | ||
| MA29942B1 (fr) | Nouveaux derives d'hydroxy-acides gras insatures et leur utilisation dermocosmetologique | |
| JP2009040767A5 (https=) | ||
| WO2006103274A8 (fr) | Inhibiteurs d'age | |
| JP2016537432A5 (https=) | ||
| JPWO2022221227A5 (https=) | ||
| JP2008508251A5 (https=) | ||
| JPWO2020065028A5 (https=) | ||
| ATE444946T1 (de) | Verzweigte carbonsäureverbindung und deren verwendung | |
| HRP20201402T1 (hr) | Spojevi inhibitora acetilkolinsteraze i agonisti serotonergičkih receptora 5ht4, s promnezijskim učinkom, postupci za njihovu pripremu i farmaceutski pripravci koji ih sadržavaju | |
| MX2023008250A (es) | Compuestos de derivados sustituidos en 4,6 de ip4. | |
| ATE540964T1 (de) | Neue mehrfach ungesättigte verbindungen, verfahren zu deren herstellung zusammensetzungen, die diese enthalten | |
| JP2009535314A5 (https=) | ||
| RU2021107724A (ru) | Донекоприд как нейропротекторный агент при лечении нейродегенеративных заболеваний | |
| JP2008546652A5 (https=) | ||
| JPWO2021100029A5 (https=) |